Cointime

Download App
iOS & Android

Arcus Biosciences

company
Funding Round
Post-IPO Equity
Money Raised
$ 200M
Propotion
-
Post Valuation
-

Current Round Investors

Investor Name Invest Money Lead Investor Propotion
Gilead Sciences - Yes - Detail

Historical Financing

Announced Date Round Money Raised Investors
Nov 13, 2017 Series C $ 107M Aisling Capital,Biotechnology Value Fund,etc. Detail
May 1, 2015 Series A $ 49.70M Celgene,The Column Group Detail
Sep 1, 2016 Series B $ 70M Celgene,Droia Ventures,etc. Detail
Mar 14, 2018 IPO $ 120M Detail